Farther Finance Advisors LLC boosted its position in Genpact Limited (NYSE:G – Free Report) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,030 shares of the business services provider’s stock after purchasing an additional 583 shares during the quarter. Farther Finance Advisors LLC’s holdings in Genpact were worth $560,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. SRH Advisors LLC acquired a new stake in shares of Genpact in the 4th quarter worth $26,000. Manchester Capital Management LLC acquired a new stake in shares of Genpact in the 4th quarter worth $38,000. Smartleaf Asset Management LLC increased its stake in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after acquiring an additional 783 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after acquiring an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp increased its stake in shares of Genpact by 38.8% in the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock worth $69,000 after acquiring an additional 453 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Stock Performance
Shares of Genpact stock opened at $50.12 on Monday. The business has a 50-day moving average of $49.57 and a 200 day moving average of $44.30. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The stock has a market capitalization of $8.80 billion, a price-to-earnings ratio of 17.65, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.36%. This is a boost from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is 23.94%.
Insider Activity at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares of the company’s stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of analysts have issued reports on the company. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and raised their target price for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC raised their target price on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and increased their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Mizuho increased their price target on Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Genpact currently has an average rating of “Hold” and an average target price of $48.44.
Check Out Our Latest Research Report on Genpact
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- What is diluted earnings per share (Diluted EPS)?
- How to Build the Ultimate Everything ETF Portfolio
- Investing in Travel Stocks Benefits
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.